The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
The DOI matches its Crossref record; 218 of the 220 references it cites were found in a registry or an index.
Abstract
Beside the well-known deficiency in serotonergic neurotransmission as pathophysiological correlate of major depression (MD), recent evidence points to a pivotal role of increased glutamate receptor activation as well. However, cause and interaction of these neurotransmitter alterations are not understood. In this review, we present a hypothesis integrating current concepts of neurotransmission and hypothalamus-pituitary-adrenal (HPA) axis dysregulation with findings on immunological alterations and alterations in brain morphology in MD. An immune activation including increased production of proinflammatory cytokines has repeatedly been described in MD. Proinflammatory cytokines such as interleukin-2, interferon-gamma, or tumor necrosis factor-alpha activate the tryptophan- and serotonin-degrading enzyme indoleamine 2,3-dioxygenase (IDO). Depressive states during inflammatory somatic disorders are also associated with increased proinflammatory cytokines and increased consumption of tryptophan via activation of IDO. An enhanced consumption of serotonin and its precursor tryptophan through IDO activation could well explain the reduced availability of serotonergic neurotransmission in MD. An increased activation of IDO and its subsequent enzyme kynurenine monooxygenase by proinflammatory cytokines, moreover, leads to an enhanced production of quinolinic acid, a strong agonist of the glutamatergic N-methyl-D-aspartate receptor. In inflammatory states of the central nervous system, IDO is mainly activated in microglial cells, which preferentially metabolize tryptophan to the NMDA receptor agonist quinolinic acid, whereas astrocytes - counteracting this metabolism due to the lack of an enzyme of this metabolism - have been observed to be reduced in MD. Therefore the type 1/type 2 immune response imbalance, associated with an astrocyte/microglia imbalance, leads to serotonergic deficiency and glutamatergic overproduction. Astrocytes are further strongly involved in re-uptake and metabolic conversion of glutamate. The reduced number of astrocytes could contribute to both, a diminished counterregulation of IDO activity in microglia and an altered glutamatergic neurotransmission. Further search for antidepressant agents should take into account anti-inflammatory drugs, for example, cyclooxygenase-2 inhibitors, might exert antidepressant effects by acting on serotonergic deficiency, glutamatergic hyperfunction and antagonizing neurotoxic effects of quinolinic acid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An alternative explanation for the involvement of IDO in the pathophysiology of depression-like behaviour is that degradation of tryptophan along the kynurenine pathway generates compounds that act as either agonists (for example, quinolinic acid and 3 hydroxy-kynurenine) or antagonists (for example, kynurenic acid) of the NMDA (N-methyl-D-aspartate) receptor (BOX 1).”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [61]
In the citing paper
“cytokine-induced activation of the enzyme, indolamine 2,3 dioxygenase (IDO), which metabolizes tryptophan to kynurenine and quinolinic acid, is believed to contribute to reduced availability of serotonin.16,23,24”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [23]
In the citing paper
“one hypothesis postulates that proinflammatory cytokines stimulate indoleamine 2,3-dioxygenase (IDO) in glial cells to convert tryptophan to kynurenine which is transformed into the neurotoxic quinolinic acid inside the brain (Müller and Schwarz, 2007;Walker et al., 2014).”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Müller and Schwarz, 2007
In the citing paper
“kynurenic acid is an N-methyl d-aspartate (NMDA) receptor antagonist, and is generally considered neuroprotective”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Müller and Schwarz, 2007
Citations
Cites
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Rates and risk of postpartum depression – a meta-analysis
O'hara, M. W., & Swain, A. M. (1996) · International Review of Psychiatry · doi:10.3109/09540269609037816 · Cited by 3,116
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Davis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Research works printed but not linked: 5
- Matussek N . Neurobiologie und depression. Med Monatsschr 1966; 3: 109–112.
- Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Anderson DN . The role of pterins and related factors in the biology of early postpartum depression. Eur Neuropsychopharmacol 1999; 9: 295–300.
- Rajkowska G . Astroglia in the cortex of schizophrenics: histopathology finding. World J Biol Psychiatry 2005; 6: 74.
- Thomas K . Immunomodulation in Mice Induced by the Antidepressant Drug Zimeldine. Thesis, University of Utrecht: Utrecht, 1989.
- Song C, Leonard BE . An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 1994; 22: 313–314.
Cited by
Items 401–500 of 681
Ren, H., Lin, F., Wu, L., Tan, L., Lu, L., Xie, X., Zhang, Y., Bao, Y., Ma, Y., Huang, X., et al. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114237 · Cited by 17
Nuovi sviluppi dell’ipotesi serotoninergica della depressione: shunt del triptofano
Marazziti, D., Baroni, S., Picchetti, M., Piccinni, A., Silvestri, S., & Dell’Osso, L. (2013) · Rivista di psichiatria · doi:10.1708/1228.13612 · Cited by 25
Archer, T., Kostrzewa, R. M., Palomo, T., & Beninger, R. J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9161-7 · Cited by 16
Henkel, A. W., Alali, H. N., Devassy, A. M., Alawadhi, M. M., & Redzic, Z. B. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.012 · Cited by 16
Lebouché, B., Jenabian, M.-A., Singer, J., Graziani, G. M., Engler, K., Trottier, B., Thomas, R., Brouillette, M., & Routy, J. (2014) · Trials · doi:10.1186/1745-6215-15-390 · Cited by 17
Paoletti, A. M., Orrù, M., Marotto, M. F., Pilloni, M., Zedda, P., Fais, M. F., Piras, B., Camilla, P., Pala, S., Lello, S., et al. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.801447 · Cited by 16
Increased indoleamine 2,3-dioxygenase (IDO) activity in idiopathic generalized epilepsy
Liimatainen, S., Lehtimäki, K. A., Raitala, A., Peltola, M., Oja, S. S., Peltola, J., & Hurme, M. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.02.003 · Cited by 17
Mitochondrial dysfunction in depression: Mechanisms and targeted therapy strategies
Xue, X., Li, K., Jiang, B., Zou, W., & Wang, L. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104694 · Cited by 22
Wang, L., Feng, Z., Zheng, T., Dai, G., Wang, M., Zhou, L., Zheng, Y., & Chen, G. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110675 · Cited by 15
Lee, H., Lee, Y., Chung, C., Park, S., Shin, H. J., Joe, E.-H., Lee, S. J., Kim, D. W., Jo, S., & Choi, S. (2024) · Glia · doi:10.1002/glia.24629 · Cited by 15
Stachowicz, K. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173585 · Cited by 16
Brain signatures of chronic gut inflammation
Hall, C. V., Radford‐Smith, G. L., Savage, E., Robinson, C., Cocchi, L., & Moran, R. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1250268 · Cited by 16
Role of metabotropic glutamate receptors in CNS disorders
O’Connor, R. M., & Cryan, J. F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511760334.017 · Cited by 16
Gatekeepers of intestinal inflammation
Arnett, H. A., & Viney, J. L. (2009) · Inflammation Research · doi:10.1007/s00011-009-0091-x · Cited by 15
Joining the dots: neurobiological links in a functional analysis of depression
Sharpley, C. F., & Bitsika, V. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-73 · Cited by 19
Rana, P., Sharma, A. K., Jain, S., Deshmukh, P. S., Bhattacharya, S. K., Banerjee, B., & Mediratta, P. K. (2016) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0120 · Cited by 15
Möller, M., Fourie, J., & Harvey, B. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-29978-3 · Cited by 21
Viol, K., Schiepek, G. K., Kronbichler, M., Hartl, A. J., Grafetstätter, C., Strasser, P., Kastinger, A., Schöller, H. J., Reiter, E.-M., Said‐Yürekli, S., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02913-5 · Cited by 15
Elevated Serum IL-2 Levels are Associated With Major Depressive Disorder: A Case-Control Study
Suhee, F. I., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., & Islam, M. R. (2023) · Clinical Pathology · doi:10.1177/2632010x231180797 · Cited by 17
Neuroprotective astroglial response to neural damage and its relevance to affective disorders
Miguel-Hidalgo, J. J. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00054 · Cited by 16
Serotonin Modulation of Dorsoventral Hippocampus in Physiology and Schizophrenia
Kandilakis, C. L., & Papatheodoropoulos, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157253 · Cited by 18
Andreetta, F., Barnes, N. M., Wren, P. B., & Carboni, L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.05.014 · Cited by 14
Sharpley, C. F., & Bitsika, V. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2010.527008 · Cited by 15
Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice. Part 2
Stachowicz, K., Sowa-Kućma, M., Pańczyszyn-Trzewik, P., Misztak, P., Marciniak, M., Bobula, B., & Tokarski, K. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135435 · Cited by 15
Luan, M., Yang, F., Miao, M., Yuan, W., Gissler, M., Arkema, E. V., Lu, D., Li, J., & László, K. D. (2023) · BMC Medicine · doi:10.1186/s12916-023-02837-3 · Cited by 16
Management protocols of chronic Orofacial Pain: A Systematic Review
Priyank, H., Prasad, R. S., Shivakumar, S., Abdul, N. S., Pathak, A., Cervino, G., Cicciù, M., & Minervini, G. (2023) · The Saudi Dental Journal · doi:10.1016/j.sdentj.2023.04.003 · Cited by 14
Peterlik, D., Stangl, C., Bludau, A., Grabski, D., Strasser, R., Schmidt, D., Flor, P. J., & Uschold‐Schmidt, N. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.036 · Cited by 15
Inflammation associated with chronic heart failure leads to enhanced susceptibility to depression
Su, J., Wang, J., Ma, Y., Li, Q., Yang, Y., Huang, L., Wang, H., Li, H., Wang, Z., Tong, J., et al. (2019) · FEBS Journal · doi:10.1111/febs.14839 · Cited by 15
Joe, P., Clemente, J. C., Piras, E., Wallach, D. S., Robinson‐Papp, J., Boka, E., Remsen, B., Bonner, M., Kimhy, D., Goetz, D. M., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.09.019 · Cited by 15
New role of sertraline against Toxoplasma gondii ‐induced depression‐like behaviours in mice
Lan, H., Lu, Y., Zhao, X., Jin, G., Lu, J., Jin, C. H., Ma, J., Jin, X., Xu, X. M., & Piao, L. X. (2021) · Parasite Immunology · doi:10.1111/pim.12893 · Cited by 14
Sekine, A., & Fukuwatari, T. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.004 · Cited by 15
Cardiovascular disease and depression: a bidirectional relationship and its clinical implications
Wu, J., Tian, Z., Qi, Z., Liu, X., & Yu, P. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1675680 · Cited by 16
Exploring the Psychiatric Manifestations of Primary Sjögren’s Syndrome: A Narrative Review
Salehi, M., Zamiri, A., Kim, J., Texeira, C., Shah, K., & Gunturu, S. (2024) · International Journal of Rheumatology · doi:10.1155/2024/5520927 · Cited by 15
Jellen, L. C., Galvis, M. L. E., Sha, Q., Isaguirre, C., Johnson, A., Madaj, Z. B., Lewis, M. M., Sheldon, R. D., Kong, L., Huang, X., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00949-6 · Cited by 15
Poutoglidou, F., Pourzitaki, C., Μanthou, M. E., Saitis, A., Malliou, F., & Kouvelas, D. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107917 · Cited by 13
Unexpected content of kynurenine in mother’s milk and infant formulas
Marszałek‐Grabska, M., Stachniuk, A., Iwaniak, P., Gaweł, K., Sumara, A., Kocki, T., Fornal, E., Milart, P., Paluszkiewicz, P., & Turski, W. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-10075-5 · Cited by 13
Vai, B., Palladini, M., Lorenzi, C., Zanardi, R., Poletti, S., Aggio, V., & Benedetti, F. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100522 · Cited by 17
Schaefer, M., Winterer, J., Sarkar, R., Uebelhack, R., Franke, L., Heinz, A., & Friebe, A. (2008) · Psychosomatics · doi:10.1176/appi.psy.49.5.442 · Cited by 16
Hao, K., Qu, Q., Hao, H., Wang, G., Chen, Y., Liang, Y. L., & Xie, L. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054981 · Cited by 15
Is Depression “Evolutionary” or Just “Adaptive”? A Comment
Sharpley, C. F., & Bitsika, V. (2010) · Depression Research and Treatment · doi:10.1155/2010/631502 · Cited by 14
Zhou, X., Li, Y., Sun, Z., Li, M., & Ma, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1077518 · Cited by 13
Unveiling the hidden pathways: Exploring astrocytes as a key target for depression therapy
Liu, Y., Chen, L., Lin, L., Xu, C., Xiong, Y., Qiu, H., Li, X., Li, S., & Cao, H. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.04.003 · Cited by 13
Poutoglidou, F., Pourzitaki, C., Μanthou, M. E., Saitis, A., Malliou, F., & Kouvelas, D. (2021) · Inflammation · doi:10.1007/s10753-021-01560-6 · Cited by 12
RETRACTED: Exploring the role of biologics in depression
Rani, T., Behl, T., Sharma, N., Makeen, H. A., Albratty, M., Alhazmi, H. A., Meraya, A. M., Bhatia, S., & BUNGAU, S. G. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110409 · Cited by 12
RetractedDisturbed sensitive equilibrium led by stress‐induced inflammation in psychiatric illness
Zhao, H., Jin, R., & Hu, J. (2022) · General Psychiatry · doi:10.1136/gpsych-2022-100910 · Cited by 12
Yang, B., Ryu, J.-S., Rim, C., Shin, J. U., & Kwon, M. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01369-3 · Cited by 12
Neurobiology and the genetics of suicide
Wasserman, D., Marcus, S., Wasserman, J., & Rujescu, D. (2009) · doi:10.1093/med/9780198570059.003.0026 · Cited by 15
Neue Erkenntnisse zur Pathogenese und Pathophysiologie der Depression
Schüle, C., Baghai, T. C., & Rupprecht, R. (2007) · Der Nervenarzt · doi:10.1007/s00115-007-2370-5 · Cited by 22
Braun, S., Bridler, R., Müller, N., Schwarz, M., Seifritz, E., Weisbrod, M., Zgraggen, A., & Stassen, H. H. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0792-z · Cited by 12
Self-citationJia, K., Pan, S., Wu, W., Sun, Y., & Zhang, Q. (2024) · Journal of Ginseng Research · doi:10.1016/j.jgr.2024.12.002 · Cited by 12
Su, H., Ma, C.-T., Lin, C., Wu, H., Chuang, Y., Chen, L., & Tsao, C.-W. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.07.011 · Cited by 13
Molecular Imaging of Depressive Disorders
Ruhé, H. G., Visser, A. K. D., Frøkjær, V. G., Haarman, B. C. M., Klein, H. C., & Booij, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_5 · Cited by 15
Oxidative Stress in Depression
Gałecki, P. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_190 · Cited by 12
Liu, Y., Zhao, L., Zhou, M., Wang, H., Yang, N., & Dai, S.-S. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.022 · Cited by 12
Yang, F., Zhou, L., Song, J., WangJinMei, A., Yang, Y., Tang, Z.-W., & Huang, Q. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00243 · Cited by 11
Kanai, M., Funakoshi, H., & Nakamura, T. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4372 · Cited by 11
University of Veterinary Medicine Hannover
Komm, K. (2010) · Cited by 11
Gut microbiome metabolites as key actors in atherosclerosis co-depression disease
Liao, X.-X., Wu, X., Zhou, Y.-L., Li, J., Wen, Y.-L., & Zhou, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.988643 · Cited by 10
Kong, L., Zhang, Q., Wang, H., Xu, Y., Xu, C., Chen, Y., Lu, J., & Hu, S. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.006 · Cited by 10
Serum serotonin levels are elevated in patients with increased risk of rheumatoid arthritis
Wirestam, L., Martinsson, K., & Kastbom, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1081814 · Cited by 10
Poutoglidou, F., Pourzitaki, C., Μanthou, M. E., Malliou, F., Saitis, A., Tsimoulas, I., Panagiotopoulos, S., & Kouvelas, D. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00328-x · Cited by 11
Tuchaai, E., Endres, V., Jones, B., Shankar, S., Klemashevich, C. L., Sun, Y., & Wu, C. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221110647 · Cited by 12
Back to the Future: The Role of Infections in Psychopathology. Focus on OCD.
Vecchia, A. D., & Marazziti, D. (2022) · PubMed · doi:10.36131/cnfioritieditore20220407 · Cited by 13
Stapelberg, N. J. C., Branjerdporn, G., Adhikary, S. R., Johnson, S., Ashton, K. J., & Headrick, J. P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192013226 · Cited by 11
Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia
Mathai, A. J., Kanwar, J., Okusaga, O. O., Fuchs, D., Lowry, C. A., Peng, X., Giegling, I., Hartmann, A. M., Konte, B., Friedl, M., et al. (2016) · Frontiers in Public Health · doi:10.3389/fpubh.2016.00182 · Cited by 11
Ji, F., Feng, C., Qin, J., Wang, C., Zhang, D., Su, L., Wang, W., Zhang, M., Li, H., Ma, L., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01203-3 · Cited by 9
Ding, L., Xue, L., Cheng, C., Tang, K., Chen, Z., & Du, G. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111592 · Cited by 14
Kovacs, P. L., Pánczél, G., Borbola, K., Juhász, G., & Liszkay, G. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-014-9777-7 · Cited by 9
Huang, J., Zhang, P., Zhou, Y., Tong, J., Cui, Y., Tan, S., Wang, Z., Yang, F., Kochunov, P., Tian, B., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.002 · Cited by 9
C-Reactive Protein in Bipolar Disorder and Unipolar Depression
Zhang, X., Li, X., Tong, J., Li, N., & Zhang, F. (2022) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001487 · Cited by 11
Stapelberg, N. J. C., Bui, T. A., Mansour, V., Johnson, S., Branjerdporn, G., Adhikary, S. R., Ashton, K. J., Taylor, N., & Headrick, J. P. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577959 · Cited by 11
Su, L., Shuai, Y., Mou, S., Shen, Y., Shen, X., Shen, Z., & Zhang, X. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1017888 · Cited by 10
Kori, R. S., Aladkatti, R., Desai, S. D., & Das, K. K. (2017) · Journal of Young Pharmacists · doi:10.5530/jyp.2017.9.48 · Cited by 10
Inflammatory Biomarkers and Depression
Müller, N., Myint, A.-M., & Schwarz, M. (2010) · Springer eBooks · doi:10.1007/978-1-4614-0785-0_7 · Cited by 10
Self-citationFreff, J., Beins, E. C., Bröker, L., Schwarte, K., Dantas, R. L., Maj, C., Arolt, V., Dannlowski, U., Nöthen, M. M., Baune, B. T., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.003 · Cited by 9
Szalárdy, L., Molnar, M. F., Zádori, D., Cseh, E. K., Veres, G., Kovács, G. G., Vécsei, L., & Klivènyi, P. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00180 · Cited by 10
Shoji, H., Irino, Y., Yoshida, M., & Miyakawa, T. (2018) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12002 · Cited by 8
Association between infection with Toxoplasma gondii and psychiatric disorders
Maisarah, A., Mohamad, S., Husain, M., Abdullah, S., & Noordin, R. (2022) · Folia Parasitologica · doi:10.14411/fp.2022.008 · Cited by 10
Zhang, Y., Feng, Y., Zhao, Y., Feng, Y., Li, M., Wang, W., Ni, Z., Zhu, H., & Wang, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23552 · Cited by 8
The Neurobiology of Posttraumatic Stress
Johnson, S. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374851-5.00002-0 · Cited by 7
McGuinness, B. W., & Harkin, A. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_3 · Cited by 7
Interactions between glia, the immune system and pain processes during early development
Barr, G. A., & Hunter, D. A. (2014) · Developmental Psychobiology · doi:10.1002/dev.21229 · Cited by 8
Depression in patients with ankylosing spondylitis
Ma, T., Geng, Y., & Li, P. (2022) · Rheumatology & autoimmunity · doi:10.1002/rai2.12020 · Cited by 9
B vitamins as adjunct therapies for depressive disorder
Zheng, Z.-Q., Shen, L., Zhao, L., & Ji, H. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.04.007 · Cited by 6
Chronic distress and the vulnerable host: a new target for HIV treatment and prevention?
Contoreggi, C. S., Chrousos, G. P., & Mascio, M. D. (2016) · Neurobehavioral HIV Medicine · doi:10.2147/nbhiv.s86309 · Cited by 7
Increasing Resilience to Traumatic Stress: Understanding the Protective Role of Well-Being
Toole, J. T., Rice, M. A., Cargill, J., Craddock, T. J. A., Nierenberg, B. P., Klimas, N. G., FLETCHER, M. A., Morris, M., Zysman, J., & Broderick, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7828-1_6 · Cited by 7
Pathways Driving Neuroprogression in Depression: The Role of Immune Activation
Oriolo, G., Grande, I., Martín‐Santos, R., Vieta, E., & Carvalho, A. F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00010-6 · Cited by 6
Li, Y., Zhang, M., Dong, C., Xue, M., Li, J., & Wu, G. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s351136 · Cited by 7
McFarland, D. C., Walsh, L. E., Saracino, R., Nelson, C. J., Breitbart, W., & Rosenfeld, B. (2021) · Palliative and Supportive Care · doi:10.1017/s1478951520001169 · Cited by 5
“For example, inflammation associated depression may be more responsive to agents that upregulate dopamine such as bupropion, in addition to serotonin (Felger, 2017), as inflammation depletes these key neurotransmitters (Muller and Schwarz, 2007).”
BackgroundDefiniendo la depresión: materialidades endógenas, inmaterialidades exógenas
García-Martínez, J. (2021) · Debats: Revista de cultura, poder i societat · doi:10.28939/iam.debats-135-1.2 · Cited by 5
Oh, D. J., Bae, J. B., Kim, T. H., Kwak, K. P., Kim, B., Kim, S. G., Kim, J. L., Moon, S. W., Park, J. H., Ryu, S., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab194 · Cited by 7
Tryptophan hydroxylase 2 and tryptophan mediate depression by regulating serotonin levels
Bian, Q., & Wang, J. (2022) · AIP conference proceedings · doi:10.1063/5.0096466 · Cited by 6
Bridge, S., Karagiannis, S. N., & Borsini, A. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100778 · Cited by 8
The potential role of amino acids in myopia: inspiration from metabolomics
Xie, Y., Zhang, L., Chen, S., Xie, C., Tong, J., & Shen, Y. (2024) · Metabolomics · doi:10.1007/s11306-024-02207-x · Cited by 5
Khabazghazvini, B., Groer, M. E., Fuchs, D., Strassle, P. D., Lapidus, M., Sleemi, A., Cabassa, J. B., & Postolache, T. T. (2010) · International Journal on Disability and Human Development · doi:10.1515/ijdhd.2010.002 · Cited by 5
Xu, X., Wu, L.-Y., Wang, S., Yan, M., Wang, Y., Li, L., Sun, Z., & Zhao, J.-X. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1287637 · Cited by 6
Regional Changes in Brain Biomolecular Markers in a Collagen-Induced Arthritis Rat Model
Millen, A. M. E., Maluleke, T. T., Pienaar, L., Sallie, F. N., Veerappan, R., Andrén, P. E., & Baijnath, S. (2024) · Biology · doi:10.3390/biology13070516 · Cited by 5
Malfunction in GABA and Glutamate as Pathways to Depression: A Review of the Evidence
Sharpley, C. F. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s3481 · Cited by 6
The Inflammatory Hypothesis of Depression
Soskin, D. P., Cassiello-Robbins, C. F., Isacoff, O. K., & Fava, M. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.4.413 · Cited by 5
Lee, B.-H., Park, Y., Lee, S., & Shim, M. (2019) · Brain Sciences · doi:10.3390/brainsci9100253 · Cited by 5
Metadata
- Authors
- Müller, N., & Schwarz, M. J.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Venue
- Molecular Psychiatry
- Published
- 2007-04-24
- Volume
- 12
- Issue
- 11
- Pages
- 988-1000
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2002250647
- Cited by
- 670
- References
- 220
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 30 · 2023: 31 · 2022: 48 · 2021: 41 · 2020: 37 · 2019: 34 · 2018: 42 · 2017: 25 · 2016: 49 · 2015: 34 · 2014: 39 · 2013: 32 · 2012: 33
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, serotonin, glutamate, indoleamine 2,3-dioxygenase, kynurenine pathway, quinolinic acid, NMDA receptor, inflammatory cytokines, microglia, astrocytes, tryptophan metabolism, hypothalamic-pituitary-adrenal axis, immune activation, antidepressants, COX-2 inhibitors
- MeSH terms
- Animals, Depression, Humans, Hypothalamo-Hypophyseal System, Immune System, Pituitary-Adrenal System, Serotonin, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.